# GENOSS Coronary Stent Clinical Trial

Study · id `cardio:ct-nct05444452` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05444452](<https://clinicaltrials.gov/study/NCT05444452>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05444452

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

## Technical summary

Registry record NCT05444452. Randomized; no masking; primary purpose treatment. Start 2022-04-24 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 850 participants (planned count; ClinicalTrials.gov record NCT05444452, source copy `cardio:ctgov-nct05444452-2022-07-06`, retrieved 2026-10-31)
- Started: 2022-04-24 (actual) (ClinicalTrials.gov record NCT05444452, source copy `cardio:ctgov-nct05444452-2022-07-06`, retrieved 2026-10-31)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT05444452, source copy `cardio:ctgov-nct05444452-2022-07-06`, retrieved 2026-10-31)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT05444452, source copy `cardio:ctgov-nct05444452-2022-07-06`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT05444452, source copy `cardio:ctgov-nct05444452-2022-07-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05444452-2022-07-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: GENOSS Coronary Stent Clinical Trial
- Condition: Ischemic Heart Disease
- Intervention (Device): Implanatation of Genoss DES sirolimus-eluting coronary system
- Intervention (Device): Implanatation of Xience DES everolimus-eluting coronary system
- Lead sponsor: Samsung Medical Center
- Lead sponsor class: OTHER
- Collaborator: Genoss Company Limited, Suwon, Korea
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Samsung Medical Center (`cardio:org-samsung-medical-center`)

## Provenance

Content hash: 8ca7553167fe07e0acf241e43e324ae64a48f9e30673466f963e5364b10ca759
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
